Ferrières J, Sing C F, Roy M, Davignon J, Lussier-Cacan S
Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Quebec, Canada.
Arterioscler Thromb. 1994 Oct;14(10):1553-60. doi: 10.1161/01.atv.14.10.1553.
The impact of apolipoprotein (apo) E polymorphism on interindividual variation in plasma lipid, lipoprotein, and apolipoprotein levels was studied in a sample of familial hypercholesterolemic (FH) patients (147 women, 116 men) with the same mutation, a > 10-kilobase deletion of the low-density lipoprotein (LDL) receptor gene. Each trait was adjusted for concomitants (age, age squared, height, weight, weight squared) for each sex separately before the apoE genotypic effects were estimated. The relative contribution of concomitants to sample variability was found to be very different in women and in men. Allelic variation in the apoE gene was shown to explain a statistically significant portion of the variability in adjusted lipid traits. Moreover, the contribution of apoE polymorphism was different between sexes. In women, there was significant variability (P < .01) among apoE genotypes for total cholesterol, LDL cholesterol, and total and LDL apoB. In men, significant variability (P < .01) was observed among apoE genotypes in very-low-density lipoprotein (VLDL) cholesterol and triglyceride levels. Women with the epsilon 3/2 genotype had significantly lower means for total cholesterol, LDL cholesterol, and LDL apoB than women with the epsilon 3/3 genotype (P < .05). In men, the mean VLDL cholesterol was significantly higher for the epsilon 2/2 genotype and was significantly lower for the epsilon 4/2 genotype than the mean for the epsilon 3/3 genotype (P < .05). Overall, the greatest influence was associated with the epsilon 2 allele, and the LDL cholesterol-lowering effect of this allele was present only in FH women. No statistically significant apoE effect was shown on lipoprotein(a) levels in either sex.(ABSTRACT TRUNCATED AT 250 WORDS)
在一组患有相同突变(低密度脂蛋白受体基因发生大于10千碱基的缺失)的家族性高胆固醇血症(FH)患者样本(147名女性,116名男性)中,研究了载脂蛋白(apo)E多态性对血浆脂质、脂蛋白和载脂蛋白水平个体间差异的影响。在估计apoE基因型效应之前,分别针对每种性别,对每个性状进行伴随因素(年龄、年龄平方、身高、体重、体重平方)的校正。结果发现,伴随因素对样本变异性的相对贡献在女性和男性中差异很大。apoE基因的等位基因变异被证明可解释校正后脂质性状变异性的统计学显著部分。此外,apoE多态性的贡献在两性之间也有所不同。在女性中,apoE基因型在总胆固醇、低密度脂蛋白胆固醇以及总载脂蛋白B和低密度脂蛋白载脂蛋白B水平上存在显著变异性(P < 0.01)。在男性中,apoE基因型在极低密度脂蛋白(VLDL)胆固醇和甘油三酯水平上存在显著变异性(P < 0.01)。携带ε3/2基因型的女性的总胆固醇、低密度脂蛋白胆固醇和低密度脂蛋白载脂蛋白B平均值显著低于携带ε3/3基因型的女性(P < 0.05)。在男性中,携带ε2/2基因型的个体的平均VLDL胆固醇显著高于携带ε3/3基因型的个体,而携带ε4/2基因型的个体的平均VLDL胆固醇显著低于携带ε3/3基因型的个体(P < 0.05)。总体而言,最大的影响与ε2等位基因相关,且该等位基因降低低密度脂蛋白胆固醇的作用仅在FH女性中存在。在任何一种性别中,均未显示apoE对脂蛋白(a)水平有统计学显著影响。(摘要截短至250字)